P

Inventor

MUELLER GUENTER

DE59 patents
⚠️ This page may combine multiple inventors who share the name “MUELLER GUENTER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SANOFI AVENTIS DEUTSCHLAND

14 patents
US7265111B2Sep 4, 2007

Adenosine analogues and their use as pharmaceutical agents

SANOFI AVENTIS DEUTSCHLAND79 citations96
US7727989B2Jun 1, 2010

4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments

SANOFI AVENTIS DEUTSCHLAND7 citations63
US7449560B2Nov 11, 2008

Phosophoinositoglycan binding proteins

SANOFI AVENTIS DEUTSCHLAND2 citations63
US7208504B2Apr 24, 2007

Bicyclic inhibitors of hormone sensitive lipase

SANOFI AVENTIS DEUTSCHLAND2 citations63
US7049416B2May 23, 2006

Phosophoinositoglycan binding proteins

SANOFI AVENTIS DEUTSCHLAND2 citations63
US7737144B2Jun 15, 2010

Pyrimido[5,4-e][1,2,4]triazine-5-7-diones, processes for preparing them and their use

SANOFI AVENTIS DEUTSCHLAND2 citations62
US7094794B2Aug 22, 2006

Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use

SANOFI AVENTIS DEUTSCHLAND6 citations62
US7615360B2Nov 10, 2009

Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporter

SANOFI AVENTIS DEUTSCHLAND1 citations59
US7244821B2Jul 17, 2007

Use of Saccharomyces cerevisiae erg4 mutants for expressing mammalian glucose transporters

SANOFI AVENTIS DEUTSCHLAND3 citations59
US7741491B2Jun 22, 2010

Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (PTB1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes

SANOFI AVENTIS DEUTSCHLAND0 citations52
US7709466B2May 4, 2010

Pyridazinone derivatives, methods for their production and their use as pharmaceuticals

SANOFI AVENTIS DEUTSCHLAND1 citations52
US7211592B2May 1, 2007

Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom

SANOFI AVENTIS DEUTSCHLAND0 citations52
US7629126B2Dec 8, 2009

PIM-3 kinase as a target for type 2 diabetes mellitus

SANOFI AVENTIS DEUTSCHLAND0 citations48
US7227006B2Jun 5, 2007

PIM-3 kinase as a target for type 2 diabetes mellitus

SANOFI AVENTIS DEUTSCHLAND0 citations48

AVENTIS PHARMA GMBH

6 patents

HOECHST AG

5 patents

BADISCHE MASCHF GMBH

4 patents

BRAINLAB AG

2 patents

ASEA BROWN BOVERI

2 patents

BOEHRINGER MANNHEIM GMBH

2 patents

REINMAR JOHN & RAINER

2 patents

AVENTIS PHARMA SA

2 patents

BASF AG

2 patents

SANOFI AVENTIS

1 patent

CPC INTERNATIONAL INC

1 patent

ROCHE DIAGNOSTICS GMBH

1 patent

GERO HOCHTEMPERATUROEFEN GMBH

1 patent

ANT NACHRICHTENTECH

1 patent

ZEISS STIFTUNG

1 patent

MAN ENERGIE GMBH

1 patent

SIEMENS MATSUSHITA COMPONENTS

1 patent

METALLOGAL AG

1 patent

Showing the top 50 of 59 patents by PatentIndex Score.